BOXR-1011

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBOXR-1011

Drug Alias Nameanti-FOLRA CAR T-cell therapy 3 (Unum Therapeutics)anti-folate receptor alpha CAR T-cell therapy 3 (Unum Therapeutics)BOXR-1011

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionFolate receptor alpha modulators

TargetsFolate receptor alpha

Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Endometrioid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCogent Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCogent Biosciences Inc

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsCarcinoma, Endometrioid

Other Information

ATC CodeN/A